Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan
July 25, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma
July 24, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma
July 14, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)
July 10, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.
July 05, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
June 15, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
MEIP
Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research
April 13, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
March 28, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib
November 14, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast
November 07, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences
August 31, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
August 09, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast
August 02, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference
May 17, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results
May 03, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces the Date of Its First Quarter 2022 Financial Results Conference Call and Webcast
April 26, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 08, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company Highlights
March 29, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Announces the Date of Its Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
March 22, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley’s 2022 Virtual Oncology Conference
January 20, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance
January 05, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index
December 14, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals to be Featured in B. Riley Fireside Chat
December 13, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium
December 10, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data Presented at the 2021 San Antonio Breast Cancer Symposium
December 06, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 22, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Infinity Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
November 02, 2021
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Tickers
INFI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit